Goldman Sachs’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184K | Sell |
|
|||||
|
2025
Q1 | $1.15M | Buy |
|
|||||
|
2024
Q4 | $948K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $424K | Buy |
|
|||||
|
2023
Q4 | $202K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $138K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $75K | Sell |
|
|||||
|
2017
Q1 | $112K | Sell |
|
|||||
|
2016
Q4 | $169K | Sell |
|
|||||
|
2016
Q3 | $296K | Buy |
|
|||||
|
2016
Q2 | $91K | Sell |
|
|||||
|
2016
Q1 | $168K | Buy |
|
|||||
|
2015
Q4 | $131K | Sell |
|
|||||
|
2015
Q3 | $610K | Sell |
|
|||||
|
2015
Q2 | $1.44M | Buy |
|